<DOC>
	<DOCNO>NCT02028871</DOCNO>
	<brief_summary>This FDA-approved ( IND # 120700 ) study evaluate efficacy intranasal insulin reduce snack intake reduce postprandial free fatty acid level abstinent smoker .</brief_summary>
	<brief_title>Intranasal Insulin Weight Management During Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>smoker ( &gt; 10 cig/day ) past 1 year normosmic olfactory function previous/current use insulin current Diagnostic Statistical ManualIVRevised ( DSMIVR ) Axis I disorder current pregnancy ( lactation ) lifetime history endocrine disease excessive alcohol use ( &gt; 25 standard unit alcohol/week ) current use illicit drug current use smoking cessation aid ( NRT , Chantix Wellbutrin ) , psychotropic agent local infection , inflammation , structural abnormality , nasal pathology current use medication administer intranasally , include intranasal steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>